Andreas Munk Petersen

Medicine & Life Sciences

1. Anti-Bacterial Agents 31%
2. Capsules 19%
3. Child 27%
4. Child Day Care Centers 22%
5. Ciprofloxacin 21%
6. Clostridium Infections 25%
7. Cohort Studies 20%
8. Crohn Disease 53%
9. Denmark 38%
10. Diarrhea 44%
11. Dientamoeba 15%
12. Dientamoebiasis 18%
13. Disease Outbreaks 34%
14. Dysbiosis 16%
15. Epidemiology 16%
16. Escherichia coli 74%
17. Escherichia coli Infections 24%
18. Escherichia coli O104 24%
19. Extraintestinal Pathogenic Escherichia coli 18%
20. Fecal Microbiota Transplantation 65%
21. Gastroenteritis 26%
22. Gastrointestinal Microbiome 36%
23. Helicobacter pylori 34%
24. Hemolytic-Uremic Syndrome 32%
25. Inflammatory Bowel Diseases 100%
26. Irritable Bowel Syndrome 24%
27. Leukocyte L1 Antigen Complex 26%
28. MGN1703 31%
29. Microbiota 39%
30. OmpC protein 15%
31. Placebos 23%
32. Pneumococcal Vaccines 22%
33. Probiotics 19%
34. Saccharomyces boulardii 28%
35. Serogroup 25%
36. Systematic Reviews 19%
37. Therapeutics 18%
38. Toll-Like Receptor 9 24%
39. Ulcerative Colitis 51%
40. Virulence 20%
41. Whole Genome Sequencing 16%